To study the effect of centriluigation (1) prior to radioimmunoassay on the albumin concentration in urine stored at -20 #{176}C, I assayed samples from normal subjects, first, after thorough vortex-mixing and, secondly, after centriflagation. The Selective Analyzer GSA HA (Greiner Electronics AG, Langenthal, Switzerland) in our laboratory was recently taken out of service and the methods were transferred to an existing G-300 analyzer. We noticed that the proportion of samples with pathological concentrations of uric acid (>420 tmoWL) increased substantially. However, the values were ascertained to be normal when we re-analyzed the samples. As a precaution, we started to measure all samples submitted for uric acid in duplicate and noticed variations as large as 500 j.molJL between the duplicate values. This phenomenon was observed more frequently (5-10% of the samples) when the G-300 analyzer was used in a selective mode as compared with batch mode (0.2-0.5% of the samples).
Interference of RadIopaque Diagnostic Contrast
Alto, CA), the dye was co-eluted with isoleucine. The ratio of the sum of absorbance at wavelengths 440 and 570 to the absorbance at 440 nm was 14.5 for isoleucine, 12.4 for Hypaque meglumine dye. Thus, the decision as to whether the chromatographic peak is a contaminant or isoleucine is not immediately obvious. Because it rapidly (10 mm)
reaches equilibrium with extracellular components after intravenous injection, the concentration of the dye in plasma is too low to cause diagnostic problems in interpretation, but its high concentration in urine can interfere with chromatographic evaluation. Hypaque meglumine can also react with dimtrophenylhydrazjne, forming a white-grey precipitate. Its interference in this spot test, often used in screening for metabolic diseases, may also lead to falsepositive results.
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The Selective Analyzer GSA HA (Greiner Electronics AG, Langenthal, Switzerland) in our laboratory was recently taken out of service and the methods were transferred to an existing G-300 analyzer. We noticed that the proportion of samples with pathological concentrations of uric acid (>420 tmoWL) increased substantially. However, the values were ascertained to be normal when we re-analyzed the samples. As a precaution, we started to measure all samples submitted for uric acid in duplicate and noticed variations as large as 500 j.molJL between the duplicate values. This phenomenon was observed more frequently (5-10% of the samples) when the G-300 analyzer was used in a selective mode as compared with batch mode (0.2-0.5% of the samples).
In the G-300 two process tubes are used per method (sample and blank), and the contents in the tubes are aspirated through a quartz flow-cell. The process tubes are washed on the analyzer and re-cycled. Uric acid was determined by using a peroxidase-mediated reaction (CBR-Uric acid, Boehringer Mannheim, cat. no. 556718 and 565245) and 10-FL sample (final volume 510 ,L) in process tube #{149}
A reagent blank was used in process tube I. The reagent contains sodium cholate and fatty alcohol-polyglycol ether (0.3% of each in the reagent mixture) as surfactants. The reagent is frothy, and this frothiness was more pronounced in the presence of serum. We established that aspiration of the reagent through the flow-cell was responsible for the discrepancies observed. The increased frothiness of the sample-reagent mixture was the main cause for the falsely
